Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 897 - 904 of 12011 results
DOJ Releases COVID-19 Fraud Enforcement Task Force Report Touting Its Successes and Urging Lawmakers to Enact New Legislation
April 18, 2024| Blog| Viewpoint
SEC’s Enforcement Authority Over Crypto Asset Transactions Upheld (Again) in Case Against Coinbase
April 18, 2024| Blog| Viewpoint
Canada’s 2024 Federal Budget: The Time Is Now ... to Lock in Lower Tax Rates
April 17, 2024| Alert| Viewpoint
American Privacy Rights Act – Another Shot at a Comprehensive Federal Privacy Law
April 17, 2024| Blog| Viewpoint
Navigating Health Tech: Regulations for AI/ML in Medical Devices and Software
April 16, 2024| Video| Viewpoint
Cannabis Ruling Lights Path For Bankruptcy Protection
April 16, 2024| News
Supreme Court Narrows the Reach of Omission Liability Claims Under Section 10(b) of the Exchange Act
April 16, 2024| Blog| Viewpoint
Florida Lost Its CWA Permitting Power. Now What?
April 16, 2024| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|